ATE321778T1 - Maurotoxin, pi1 und hstx1 derivate - Google Patents

Maurotoxin, pi1 und hstx1 derivate

Info

Publication number
ATE321778T1
ATE321778T1 AT01980332T AT01980332T ATE321778T1 AT E321778 T1 ATE321778 T1 AT E321778T1 AT 01980332 T AT01980332 T AT 01980332T AT 01980332 T AT01980332 T AT 01980332T AT E321778 T1 ATE321778 T1 AT E321778T1
Authority
AT
Austria
Prior art keywords
derivatives
residue
maurotoxin
replaced
disulfide bridge
Prior art date
Application number
AT01980332T
Other languages
English (en)
Inventor
Jean-Marc Sabatier
Kamel Mabrouk
Herve Rochat
Original Assignee
Cellpep Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0021639A external-priority patent/GB0021639D0/en
Priority claimed from GB0024538A external-priority patent/GB0024538D0/en
Application filed by Cellpep Sa filed Critical Cellpep Sa
Application granted granted Critical
Publication of ATE321778T1 publication Critical patent/ATE321778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT01980332T 2000-09-04 2001-09-03 Maurotoxin, pi1 und hstx1 derivate ATE321778T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0021639A GB0021639D0 (en) 2000-09-04 2000-09-04 Maurotoxin derivatives
GB0024538A GB0024538D0 (en) 2000-10-06 2000-10-06 Maurotoxin pil and hstx1 derivatives

Publications (1)

Publication Number Publication Date
ATE321778T1 true ATE321778T1 (de) 2006-04-15

Family

ID=26244958

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980332T ATE321778T1 (de) 2000-09-04 2001-09-03 Maurotoxin, pi1 und hstx1 derivate

Country Status (7)

Country Link
US (2) US20040039167A1 (de)
EP (1) EP1315747B1 (de)
AT (1) ATE321778T1 (de)
AU (1) AU2002212201A1 (de)
DE (1) DE60118418T2 (de)
ES (1) ES2261491T3 (de)
WO (1) WO2002020596A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0414272D0 (en) 2004-06-25 2004-07-28 Cellpep Sa OsK1 derivatives
PE20081140A1 (es) * 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
MX2009012609A (es) * 2007-05-22 2009-12-07 Amgen Inc Composiciones y metodos para producir proteinas de fusion bioactivas.
DE202013104200U1 (de) 2013-09-13 2013-10-10 Flühs Drehtechnik GmbH Einhandhebelkartusche
AU2013404615B2 (en) 2013-10-28 2018-05-17 Baylor College Of Medicine Novel scorpion toxin analogue and method for treating autoimmune diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ83294A3 (en) * 1991-10-12 1995-08-16 Univ California The use of thioredox proteins for reducing disulfidic bonds
US6187579B1 (en) * 1993-10-28 2001-02-13 Carlsberg A/S Customized proteases
CA2253937A1 (en) * 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone
GB9627115D0 (en) * 1996-12-31 1997-02-19 Centre Nat Rech Scient Alpha-amino-butyrate derivatives of venoms

Also Published As

Publication number Publication date
EP1315747B1 (de) 2006-03-29
EP1315747A2 (de) 2003-06-04
WO2002020596A2 (en) 2002-03-14
DE60118418D1 (de) 2006-05-18
DE60118418T2 (de) 2007-01-11
ES2261491T3 (es) 2006-11-16
AU2002212201A1 (en) 2002-03-22
WO2002020596A3 (en) 2002-08-01
US7829666B2 (en) 2010-11-09
US20090062198A1 (en) 2009-03-05
US20040039167A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
DK1877435T3 (da) Glucagon-lignende peptid 2 (GLP-2)-analoger
CY1113850T1 (el) Νεα παραγωγα ινσουλινης
ATE417595T1 (de) Keratin-bindende polypeptide
BRPI0414062A (pt) uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv
BR0209312A (pt) Composição alimentìcia de isolado de proteìna de canola
MX2009004701A (es) Analogos selectivos del peptido 2 similar al glucagon.
BR122016022033B8 (pt) conjugados de polipeptídeo isolado apresentando atividade pró-coagulante de fator viii, seu uso e composição farmacêutica
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
CY1105452T1 (el) Παραγωγα της κυκλοσπορινης και μεθοδος παρασκευης των εν λογω παραγωγων
CY1115084T1 (el) Καθηλωμενα επι εκμαγειου πεπτιδομιμητικα βητα-φουρκετας με δραση αναστολης πρωτεασης
ATE321778T1 (de) Maurotoxin, pi1 und hstx1 derivate
DE60321053D1 (de) Matrizenfixierte peptidmimetika als medikamente gegen hiv und krebs
PE20010516A1 (es) Peptidos ciclicos con afinidad mejorada por los receptores de somatostatina
DE60236212D1 (de) Neue isoform des gefässendothelzell wachstumshemmers (vegi)
BRPI0411820A (pt) composição farmacêutica
GEP20084464B (en) Mutated neublastin
ATE291587T1 (de) Somatostatin analoge und deren verwendung zur behandlung von krebs
WO2002083729A3 (en) Polypeptides derived from amyloid precursor peptide (app) and their uses
CY1111301T1 (el) Πολυπεπτιδια που προερχονται απο προδρομο πεπτιδιο αμυλοειδους (αρρ) και οι χρησεις αυτων
CY1113827T1 (el) Cop 1 για την αγωγη των φλεγμονωδων παθησεων του εντερου
CY1113442T1 (el) Πεπτιδια που δεσμευονται στον υποδοχεα ερυθροποιητινης
ECSP003333A (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevos materiales (lea 33528 - ec)
ATE492637T1 (de) An die lck-sh3 und hck-sh3 domäne bindende peptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties